09/28/2026
When two or more antidepressants have not provided relief, you are not out of options.
For adults navigating treatment-resistant depression, Spravato® (esketamine) offers an FDA-approved path forward. Unlike traditional daily oral medications, Spravato is an intranasal treatment administered in a comfortable, medically supervised clinic setting to support neural pathways associated with mood regulation.
At Anaheim Community Hospital, our dedicated outpatient team provides personalized care and comprehensive monitoring throughout every step of your treatment journey.
Most major insurance plans, including Medicare, cover treatment for eligible patients.
To verify your insurance coverage or schedule a free, confidential assessment, call our team at (714) 243-9090 or visit the link in our bio.